Biogen (BIIB) Non-Current Debt (2009 - 2026)

Biogen has reported Non-Current Debt for 18 years, with the latest figure at $7.3 billion in Q2 2026.

• On a quarterly basis, Non-Current Debt rose 16.02% year-over-year to $7.3 billion in Q2 2026; TTM through Jun 2026 was $7.3 billion, a 16.02% increase from a year earlier, with the FY2025 full-year figure at $6.3 billion, up 38.26% from the prior year.
• Non-Current Debt was $7.3 billion for Q2 2026 at Biogen, up from $6.3 billion in the prior quarter.
• The five-year high for Non-Current Debt was $7.3 billion in Q2 2026, with the low at $4.5 billion in Q4 2024.
• Average Non-Current Debt over 5 years is $6.4 billion, with a median of $6.3 billion recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Non-Current Debt plunged 33.01% in 2024, then soared 38.26% in 2025.
• Over 5 years, Non-Current Debt stood at $6.3 billion in 2022, then increased by 8.08% to $6.8 billion in 2023, then slumped by 33.01% to $4.5 billion in 2024, then jumped by 38.26% to $6.3 billion in 2025, then grew by 15.96% to $7.3 billion in 2026.
• The last three Non-Current Debt figures came in at $7.3 billion (Q2 2026), $6.3 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.